Business · 13/09/2019

FDA Announces Final Guidance for Special 510(k) Program

The Food and Drug Administration (FDA) has released a final guidance document outlining the framework for reviewing premarket notifications (510(k)) for changes to predicate devices under the Special 510(k) Program, a program established to streamline the review process for manufacturers' own approved devices.